Direct cost of drug and prescribing pattern in the outpatient services of a teaching hospital in Malaysia

Research output: Contribution to journalArticle

Abstract

Objective: This study aims to impute the direct drug cost and to assess the prescribing pattern on patients getting dyslipidemia drugs at outpatients’ Pharmacy Department in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Methods: Patients receiving at least one dyslipidemia drug were randomly selected from UKMMC pharmacy electronic prescribing system from January 2012 to December 2012. The patients’ gender, age, and ethnic, and all the drugs received by the patients during the visits were recorded. The brand name of the drugs and the cost was recorded for the calculation of generic drug prescription rate (GDPR) and direct drug cost. Results: A total of 380 patients were randomly selected from the system. There were 829 prescriptions with the total amount of 5512 drugs prescribed. From the total of drugs, the number of generic drugs prescribed was 3967 (72%). The percentage of patients with GDPR of more than 75% for this study was 48% (n=183). The total drug cost for all 380 patients was RM240,244. The mean cost for each patient was RM637 (Range: RM1.20– RM27,972.30) and the median cost was RM233. The total formulary dyslipidemia drugs cost was RM11,003. The mean formulary dyslipidemia drugs cost for each patient was RM38 (Range: RM1.20–RM810), and the median cost was RM13.50. Predictors of high drug cost were GDPR of ≤75% and a number of drugs per prescription of >10. Conclusion: This study could contribute toward short-and long-term strategies to reduce the drug cost expenditure of dyslipidemia drugs in the hospital.

Original languageEnglish
Pages (from-to)120-124
Number of pages5
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume11
Issue number7
DOIs
Publication statusPublished - 1 Jul 2018

Fingerprint

Drug Prescriptions
Malaysia
Drug Costs
Ambulatory Care
Teaching Hospitals
Costs and Cost Analysis
Generic Drugs
Dyslipidemias
Pharmaceutical Preparations
Formularies
Electronic Prescribing
Health Expenditures
Names
Prescriptions
Outpatients

Keywords

  • Drug cost
  • Dyslipidemia drugs
  • Generic drugs prescribing rate

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

@article{aaf6ef2bd3fd4ad09068f452b7518b90,
title = "Direct cost of drug and prescribing pattern in the outpatient services of a teaching hospital in Malaysia",
abstract = "Objective: This study aims to impute the direct drug cost and to assess the prescribing pattern on patients getting dyslipidemia drugs at outpatients’ Pharmacy Department in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Methods: Patients receiving at least one dyslipidemia drug were randomly selected from UKMMC pharmacy electronic prescribing system from January 2012 to December 2012. The patients’ gender, age, and ethnic, and all the drugs received by the patients during the visits were recorded. The brand name of the drugs and the cost was recorded for the calculation of generic drug prescription rate (GDPR) and direct drug cost. Results: A total of 380 patients were randomly selected from the system. There were 829 prescriptions with the total amount of 5512 drugs prescribed. From the total of drugs, the number of generic drugs prescribed was 3967 (72{\%}). The percentage of patients with GDPR of more than 75{\%} for this study was 48{\%} (n=183). The total drug cost for all 380 patients was RM240,244. The mean cost for each patient was RM637 (Range: RM1.20– RM27,972.30) and the median cost was RM233. The total formulary dyslipidemia drugs cost was RM11,003. The mean formulary dyslipidemia drugs cost for each patient was RM38 (Range: RM1.20–RM810), and the median cost was RM13.50. Predictors of high drug cost were GDPR of ≤75{\%} and a number of drugs per prescription of >10. Conclusion: This study could contribute toward short-and long-term strategies to reduce the drug cost expenditure of dyslipidemia drugs in the hospital.",
keywords = "Drug cost, Dyslipidemia drugs, Generic drugs prescribing rate",
author = "Lee, {Sit Wai} and {Syed Junid}, {Syed Mohamed Al-Junid}",
year = "2018",
month = "7",
day = "1",
doi = "10.22159/ajpcr.2018.v11i7.22331",
language = "English",
volume = "11",
pages = "120--124",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Asian Journal of Pharmaceutical and Clinical Research",
number = "7",

}

TY - JOUR

T1 - Direct cost of drug and prescribing pattern in the outpatient services of a teaching hospital in Malaysia

AU - Lee, Sit Wai

AU - Syed Junid, Syed Mohamed Al-Junid

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Objective: This study aims to impute the direct drug cost and to assess the prescribing pattern on patients getting dyslipidemia drugs at outpatients’ Pharmacy Department in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Methods: Patients receiving at least one dyslipidemia drug were randomly selected from UKMMC pharmacy electronic prescribing system from January 2012 to December 2012. The patients’ gender, age, and ethnic, and all the drugs received by the patients during the visits were recorded. The brand name of the drugs and the cost was recorded for the calculation of generic drug prescription rate (GDPR) and direct drug cost. Results: A total of 380 patients were randomly selected from the system. There were 829 prescriptions with the total amount of 5512 drugs prescribed. From the total of drugs, the number of generic drugs prescribed was 3967 (72%). The percentage of patients with GDPR of more than 75% for this study was 48% (n=183). The total drug cost for all 380 patients was RM240,244. The mean cost for each patient was RM637 (Range: RM1.20– RM27,972.30) and the median cost was RM233. The total formulary dyslipidemia drugs cost was RM11,003. The mean formulary dyslipidemia drugs cost for each patient was RM38 (Range: RM1.20–RM810), and the median cost was RM13.50. Predictors of high drug cost were GDPR of ≤75% and a number of drugs per prescription of >10. Conclusion: This study could contribute toward short-and long-term strategies to reduce the drug cost expenditure of dyslipidemia drugs in the hospital.

AB - Objective: This study aims to impute the direct drug cost and to assess the prescribing pattern on patients getting dyslipidemia drugs at outpatients’ Pharmacy Department in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Methods: Patients receiving at least one dyslipidemia drug were randomly selected from UKMMC pharmacy electronic prescribing system from January 2012 to December 2012. The patients’ gender, age, and ethnic, and all the drugs received by the patients during the visits were recorded. The brand name of the drugs and the cost was recorded for the calculation of generic drug prescription rate (GDPR) and direct drug cost. Results: A total of 380 patients were randomly selected from the system. There were 829 prescriptions with the total amount of 5512 drugs prescribed. From the total of drugs, the number of generic drugs prescribed was 3967 (72%). The percentage of patients with GDPR of more than 75% for this study was 48% (n=183). The total drug cost for all 380 patients was RM240,244. The mean cost for each patient was RM637 (Range: RM1.20– RM27,972.30) and the median cost was RM233. The total formulary dyslipidemia drugs cost was RM11,003. The mean formulary dyslipidemia drugs cost for each patient was RM38 (Range: RM1.20–RM810), and the median cost was RM13.50. Predictors of high drug cost were GDPR of ≤75% and a number of drugs per prescription of >10. Conclusion: This study could contribute toward short-and long-term strategies to reduce the drug cost expenditure of dyslipidemia drugs in the hospital.

KW - Drug cost

KW - Dyslipidemia drugs

KW - Generic drugs prescribing rate

UR - http://www.scopus.com/inward/record.url?scp=85049835349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049835349&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2018.v11i7.22331

DO - 10.22159/ajpcr.2018.v11i7.22331

M3 - Article

AN - SCOPUS:85049835349

VL - 11

SP - 120

EP - 124

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 7

ER -